BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

557 related articles for article (PubMed ID: 32765502)

  • 1. Structural Understanding of Interleukin 6 Family Cytokine Signaling and Targeted Therapies: Focus on Interleukin 11.
    Metcalfe RD; Putoczki TL; Griffin MDW
    Front Immunol; 2020; 11():1424. PubMed ID: 32765502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-6 and interleukin-11: same same but different.
    Garbers C; Scheller J
    Biol Chem; 2013 Sep; 394(9):1145-61. PubMed ID: 23740659
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The structure of human interleukin-11 reveals receptor-binding site features and structural differences from interleukin-6.
    Putoczki TL; Dobson RC; Griffin MD
    Acta Crystallogr D Biol Crystallogr; 2014 Sep; 70(Pt 9):2277-85. PubMed ID: 25195742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of the signal transducer glycoprotein 130 by both IL-6 and IL-11 requires two distinct binding epitopes.
    Kurth I; Horsten U; Pflanz S; Dahmen H; Küster A; Grötzinger J; Heinrich PC; Müller-Newen G
    J Immunol; 1999 Feb; 162(3):1480-7. PubMed ID: 9973404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-11 signaling as a therapeutic target for cancer.
    Putoczki TL; Ernst M
    Immunotherapy; 2015; 7(4):441-53. PubMed ID: 25917632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pleiotropy and Specificity: Insights from the Interleukin 6 Family of Cytokines.
    Murakami M; Kamimura D; Hirano T
    Immunity; 2019 Apr; 50(4):812-831. PubMed ID: 30995501
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A panoramic review and in silico analysis of IL-11 structure and function.
    Negahdaripour M; Nezafat N; Ghasemi Y
    Cytokine Growth Factor Rev; 2016 Dec; 32():41-61. PubMed ID: 27312790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway.
    Heinrich PC; Behrmann I; Müller-Newen G; Schaper F; Graeve L
    Biochem J; 1998 Sep; 334 ( Pt 2)(Pt 2):297-314. PubMed ID: 9716487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro reconstitution of recognition and activation complexes between interleukin-6 and gp130.
    Chow D; Ho J; Nguyen Pham TL; Rose-John S; Garcia KC
    Biochemistry; 2001 Jun; 40(25):7593-603. PubMed ID: 11412113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of proteolysis in interleukin-11 signaling.
    Lokau J; Kespohl B; Kirschke S; Garbers C
    Biochim Biophys Acta Mol Cell Res; 2022 Jan; 1869(1):119135. PubMed ID: 34624437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-6: A Masterplayer in the Cytokine Network.
    Uciechowski P; Dempke WCM
    Oncology; 2020; 98(3):131-137. PubMed ID: 31958792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-6 and its receptors: a highly regulated and dynamic system.
    Wolf J; Rose-John S; Garbers C
    Cytokine; 2014 Nov; 70(1):11-20. PubMed ID: 24986424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soluble gp130 prevents interleukin-6 and interleukin-11 cluster signaling but not intracellular autocrine responses.
    Lamertz L; Rummel F; Polz R; Baran P; Hansen S; Waetzig GH; Moll JM; Floss DM; Scheller J
    Sci Signal; 2018 Oct; 11(550):. PubMed ID: 30279168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-11 is the dominant IL-6 family cytokine during gastrointestinal tumorigenesis and can be targeted therapeutically.
    Putoczki TL; Thiem S; Loving A; Busuttil RA; Wilson NJ; Ziegler PK; Nguyen PM; Preaudet A; Farid R; Edwards KM; Boglev Y; Luwor RB; Jarnicki A; Horst D; Boussioutas A; Heath JK; Sieber OM; Pleines I; Kile BT; Nash A; Greten FR; McKenzie BS; Ernst M
    Cancer Cell; 2013 Aug; 24(2):257-71. PubMed ID: 23948300
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging roles for IL-11 signaling in cancer development and progression: Focus on breast cancer.
    Johnstone CN; Chand A; Putoczki TL; Ernst M
    Cytokine Growth Factor Rev; 2015 Oct; 26(5):489-98. PubMed ID: 26209885
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Principles of interleukin (IL)-6-type cytokine signalling and its regulation.
    Heinrich PC; Behrmann I; Haan S; Hermanns HM; Müller-Newen G; Schaper F
    Biochem J; 2003 Aug; 374(Pt 1):1-20. PubMed ID: 12773095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural Basis of IL-1 Family Cytokine Signaling.
    Fields JK; Günther S; Sundberg EJ
    Front Immunol; 2019; 10():1412. PubMed ID: 31281320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-6 is a direct mediator of T cell migration.
    Weissenbach M; Clahsen T; Weber C; Spitzer D; Wirth D; Vestweber D; Heinrich PC; Schaper F
    Eur J Immunol; 2004 Oct; 34(10):2895-906. PubMed ID: 15368306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissecting the molecular control of Interleukin 6 signaling using the M1 cell line.
    Morris R; Hilton DJ; Jarratt A; Babon JJ
    Cytokine; 2021 Oct; 146():155624. PubMed ID: 34166855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hiding in Plain Sight: Interleukin-11 Emerges as a Master Regulator of Fibrosis, Tissue Integrity, and Stromal Inflammation.
    Cook SA; Schafer S
    Annu Rev Med; 2020 Jan; 71():263-276. PubMed ID: 31986085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.